Physician profile

William Starr Mclean

Orthopaedic Surgery · Demorest, GA

NPI 1427024173

$289.76

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$48.45

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ethicon US, LLC $62.33 2021-2022
Organogenesis INC. $56.91 2021-2022
Medline Industries LP $27.19 2022
Smith+Nephew, INC. $26.98 2023 Bone Anchors With Arthroscopic Delivery System
Depuy Synthes Sales INC. $25.86 2019
Orthofix Medical, INC. $25.12 2019-2021
Heron Therapeutics, INC. $21.47 2023 Zynrelef
Baudax Bio INC. $15.27 2022
Heraeus Medical, LLC. $14.88 2021
Baxter Healthcare $13.75 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

William Starr Mclean

$289.76

in general payments reported 2019-2025

Years
2019-2023
Top company
Ethicon US, LLC

https://glasscript.com/doctor/337343/william-starr-mclean

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.